Literature DB >> 2848061

Laboratory infection with parvovirus B19.

B J Cohen, A M Couroucé, T F Schwarz, K Okochi, G J Kurtzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2848061      PMCID： PMC1141671          DOI： 10.1136/jcp.41.9.1027-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  6 in total

1.  [Incidence of parvovirus B19 infection. Seroepidemiologic studies].

Authors:  T F Schwarz; M Roggendorf; F Deinhardt
Journal:  Dtsch Med Wochenschr       Date:  1987-10-02       Impact factor: 0.628

2.  Varicella zoster immunoglobulin to prevent neonatal chickenpox.

Authors:  B Bose; M Kerr; E Brookes
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

3.  Inactivation of thirty viruses by gamma radiation.

Authors:  R Sullivan; A C Fassolitis; E P Larkin; R B Read; J T Peeler
Journal:  Appl Microbiol       Date:  1971-07

4.  Infections in British clinical laboratories, 1984-5.

Authors:  N R Grist; J A Emslie
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

5.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

6.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226
  6 in total
  6 in total

1.  New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.

Authors:  T F Schwarz; S Modrow; B Hottenträger; B Höflacher; G Jäger; W Scharti; R Sumazakl; H Wolf; J Middeldorp; M Roggendorf
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Infections in British clinical laboratories, 1986-87.

Authors:  N R Grist; J A Emslie
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

3.  A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

Authors:  S Kajigaya; T Shimada; S Fujita; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 4.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 5.  Laboratory-associated infections and biosafety.

Authors:  D L Sewell
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 6.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.